Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E. S. van Hattum"'
Autor:
R. J. C. M. F. de Kleijn, L. Schropp, J. Westerink, M. Nijkeuter, J. van Laanen, J. Teijink, C. Ünlu, A. W. F. Vos, E. S. van Hattum, B. J. Petri, G. J. de Borst
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
IntroductionCurrent treatment strategies for primary upper extremity deep venous thrombosis (pUEDVT) range from conservative treatment with anticoagulation therapy to invasive treatment with thoracic outlet decompression surgery (TOD), frequently com
Externí odkaz:
https://doaj.org/article/909cdad63f27412bb08e4906c3bb2274
Publikováno v:
Thrombosis and Haemostasis. 108:543-553
SummaryPatients with peripheral arterial disease (PAD) are at high risk of major ischaemic events. Long-term data of all major ischaemic events in PAD patients are scarce and outdated, especially for patients with severe PAD requiring bypass surgery.
Autor:
E. S. van Hattum, M.A. Huis in ’t Veld, Marco J.D. Tangelder, A. Algra, J.A. Lawson, F.L. Moll
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 41(6):805-813
Objective The Dutch Bypass and Oral anticoagulants or Aspirin (BOA) Study demonstrated that in patients with peripheral arterial disease after bypass surgery oral anticoagulants were more effective in preventing venous graft occlusions than aspirin,
Autor:
Marco J.D. Tangelder, P.P. Wisman, E. S. van Hattum, Y. van der Graaf, G.J. Dr Borst, F.L. Moll
Publikováno v:
European Heart Journal. 34:P5167-P5167
Purpose: Major cardiovascular events occur frequently in patients with peripheral arterial disease (PAD). A prediction model to identify determinants and quantify the risk of future ischaemic events could provide a personal risk profile to offer indi